Jain Global’s Skye Bioscience SKYE Stock Holding History

Jain Global’s Portfolio SKYE Stock Details SKYE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-19,852	Closed	-$83K	–	1587
2025 Q2	$83K	Buy	+19,852	New	+$41.1K	﹤0.01%	1055

Other funds holding SKYE

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jain Global's SKYE Position: Q3 2025 in Review

Jain Global sold out of Skye Bioscience (SKYE) in Q3 2025, closing a stake of 19,852 shares — an estimated $83K sold.

Jain Global first reported a position in SKYE in Q2 2025 and held it in 1 quarter. The position peaked at $83K in Q2 2025. 58 funds tracked by Wall St. Rank hold SKYE as of Q3 2025.

Jain Global reported no remaining Skye Bioscience position as of Q3 2025 after selling out during the quarter.
Jain Global sold 19,852 Skye Bioscience shares in Q3 2025, an estimated $83K.
Jain Global first reported a position in Skye Bioscience in Q2 2025 and held it in 1 quarter.
Jain Global's Skye Bioscience position peaked at $83K in Q2 2025.
58 funds tracked by Wall St. Rank held Skye Bioscience as of Q3 2025.

Based on Jain Global's 13F filing for Q3 2025, filed 14 Nov 2025.